Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
203 Platelet-rich plasma (PRP) intraarticular injection, commonly used for OA treatment, 204 has been proven to inhibit mitochondrial damage mediated by LPS through diminishing ROS production, inhibiting DRP1 expression, and upregulating MFN1 expression, eventually repairing mitochondrial function
X.ParysC.et al
Its sequence allows it to remain active in a variety of experimental conditions, making it suitable for long-term studies, repeated testing, and controlled variable experiments where peptide degradation is a concern
PMID: 25182964
Storage and handling Store as labelled
US$ 21.82
US$ 23.68
US$ 28.62
US$ 20.47
US$ 21.49
US$ 20.84
US$ 24.87
US$ 29.74
US$ 25.41
US$ 20.85
US$ 28.43
